Author

Xinyuan Tang

Institution: Guangdong Pharmaceutical University

Observed institutions: Guangdong Pharmaceutical University, State Administration of Traditional Chinese Medicine of the People's Republic of China

ORCID: 0000-0002-3530-6603

Observed ORCID: 0000-0002-3530-6603

OpenAlex ID: A5021269560

Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA

2023 · Yue Zhang, Ruonan Wang, et al. · Journal of Ethnopharmacology · 26

Lactylation Modification in Cardiometabolic Disorders: Function and Mechanism

2024 · Xu Li, Pingdong Cai, et al. · Metabolites · 25

The Roles of Exosome-Derived microRNAs in Cardiac Fibrosis

2024 · Xinyuan Tang, Mingyang Leng, et al. · Molecules · 17

BAG3 Alleviates Atherosclerosis by Inhibiting Endothelial-to-Mesenchymal Transition via Autophagy Activation

2022 · Hongtao Diao, Kaili Wu, et al. · Genes · 17

The Traditional Chinese Medicine Formula FTZ Protects against Cardiac Fibrosis by Suppressing the TGFβ1-Smad2/3 Pathway

2022 · Yue Zhang, Dongwei Wang, et al. · Evidence-based Complementary and Alternative Medicine · 4

METTL1‐Mediated N 7 ‐Methylguanosine tRNA Modification Alleviates Cardiac Ischemia/Reperfusion Injury by Modulating Mitochondrial Energy Metabolism

2026 · Yue Zhang, Mingyang Leng, et al. · MedComm · 3

Works count: 6

Citation count: 92

H-index: 4

I10-index: 4